Neurology. 1976 Aug;26(8):777-80.

Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.

Achar VS, Welch KM, Chabi E, Bartosh K, Meyer JS.

Abstract

Cerebrospinal fluid gamma-aminobutyric acid (CSF GABA) was analyzed in 151 patients who underwent evaluation for central nervous system disease. CSF GABA was not detected in 19 of these patients, who had no evidence of neurologic disease and who served as controls. GABA was most frequently detected in patients with cerebrovascular disease, and was detected only in Parkinson's syndrome of atherosclerotic origin and dementia of multi-infarct type. CSF GABA was not detected in Alzheimer's disease or Huntington's disease. Patients with grand mal seizures exhibited CSF GABA elevation within 24 hours of the ictus. In patients with multiple sclerosis GABA detection was related to the presence or exacerbation of spinal cord lesions. Further study is necessary to evaluate the significance of elevated CSF GABA in central nervous system disease.

PMID:: 133299; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, U.S. Gov't, P.H.S.

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Ovid Technologies, Inc.

Medical

Neurologic Diseases - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. [Arch Neurol. 1980]
Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
Manyam NV, Katz L, Hare TA, Gerber JC 3rd, Grossman MH. Arch Neurol. 1980 Jun; 37(6):352-5.
Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid. [Brain Res. 1984]
Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
Manyam BV, Tremblay RD. Brain Res. 1984 Jul 30; 307(1-2):217-23.
Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders. [Arch Neurol. 1977]
Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
Enna SJ, Stern LZ, Wastek GJ, Yamamura HI. Arch Neurol. 1977 Nov; 34(11):683-5.
Review Clinical relevance of measuring GABA concentrations in cerebrospinal fluid. [Neurochem Res. 1990]
Review Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.
Schechter PJ, Sjoerdsma A. Neurochem Res. 1990 Apr; 15(4):419-23.
Review Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid. [Mol Cell Biochem. 1981]
Review Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.
Hare TA. Mol Cell Biochem. 1981 Sep 25; 39:297-304.

See reviews... See all...

Cited by 2 PubMed Central articles

Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders. [J Neurol Neurosurg Psychiatry....]
Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.
Schmidt D, Löscher W. J Neurol Neurosurg Psychiatry. 1982 Oct; 45(10):931-5.
The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry. [J Neurol Neurosurg Psychiatry....]
The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry.
Francis DA, Grundy D, Heron JR. J Neurol Neurosurg Psychiatry. 1986 Jan; 49(1):87-9.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
Neurology. 1976 Aug ;26(8):777-80.

PubMed
The stability of potassium iodate in crude table salt.
The stability of potassium iodate in crude table salt.
Bull World Health Organ. 1956 ;14(1):183-5.

PubMed
Transforming growth factor-beta: recent progress and new challenges.
Transforming growth factor-beta: recent progress and new challenges.
J Cell Biol. 1992 Dec ;119(5):1017-21.

PubMed
Tetanus and the anaesthetist; a review of the symptomatology and the recent adva...
Tetanus and the anaesthetist; a review of the symptomatology and the recent advances in treatment.
Br J Anaesth. 1956 Jun ;28(6):258-73.

PubMed
Effective outpatient drug treatment organizations: program features and selectio...
Effective outpatient drug treatment organizations: program features and selection effects.
Int J Addict. 1992 Nov ;27(11):1335-58.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: